Roche Scoops Up Verum Diagnostica

Law360, New York (December 5, 2011, 2:35 PM EST) -- Swiss pharmaceutical and diagnostics giant F. Hoffmann-La Roche Ltd. will acquire Verum Diagnostica GmbH for at least $14.8 million to help grow its blood clotting testing business, Roche announced Monday.

Roche will pay shareholders of the German company — a wholly owned subsidiary of Dynabyte Informationssysteme GmbH — $14.8 million and potentially $2.7 million more based on certain performance-related milestones, according to the company. The deal is expected to close in January.

Munich-based Verum Diagnostica makes the Multiplate analyzer for testing the functioning of blood platelets,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.